Nicastro, Nicolas http://orcid.org/0000-0002-5836-0792
Rodriguez, Patricia Vazquez
Malpetti, Maura
Bevan-Jones, William Richard
Simon Jones, P.
Passamonti, Luca
Aigbirhio, Franklin I.
O’Brien, John T.
Rowe, James B.
Funding for this research was provided by:
National Institute for Health Research (RG64473)
PSP Association
Wellcome Trust (103838)
Medical Research Council (MC-A060-5PQ30)
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research (-)
Article History
Received: 6 September 2019
Revised: 27 September 2019
Accepted: 30 September 2019
First Online: 22 October 2019
Compliance with ethical standards
:
: N. Nicastro, P. Vazquez-Rodriguez, M. Malpetti, W.R. Bevan-Jones, P. Simon Jones, L. Passamonti report no disclosures relevant to the present manuscript. F. I. Aigbirhio has served as review editor for <i>Journal of Labelled Compounds and Radiopharmaceuticals</i>, received academic grant support from GE Healthcare, and served as a consultant for Avid and Cantabio, all for matters not related to the current study. J. T. O’Brien has served as deputy editor of <i>International Psychogeriatrics</i>, received grant support from Avid (Lilly), and served as a consultant for Avid and GE Healthcare, all for matters not related to the current study. J. B. Rowe serves as editor to <i>Brain</i>, has been a consultant for Asceneuron and Syncona, and has received academic grant funding from AZ-MedImmune, Janssen, and Lilly, unrelated to this study.
: The present study was performed in agreement with the Declaration of Helsinki and its further amendments. Approval was obtained from Ethics Committee from East of England (Cambridge Central Research, Ref. 13/EE/0104).
: Informed consent has been obtained from all participants in the present study.